BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

621 related articles for article (PubMed ID: 9916804)

  • 1. Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides.
    Marsh DJ; Hollopeter G; Huszar D; Laufer R; Yagaloff KA; Fisher SL; Burn P; Palmiter RD
    Nat Genet; 1999 Jan; 21(1):119-22. PubMed ID: 9916804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass.
    Chen AS; Marsh DJ; Trumbauer ME; Frazier EG; Guan XM; Yu H; Rosenblum CI; Vongs A; Feng Y; Cao L; Metzger JM; Strack AM; Camacho RE; Mellin TN; Nunes CN; Min W; Fisher J; Gopal-Truter S; MacIntyre DE; Chen HY; Van der Ploeg LH
    Nat Genet; 2000 Sep; 26(1):97-102. PubMed ID: 10973258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome.
    Fan W; Boston BA; Kesterson RA; Hruby VJ; Cone RD
    Nature; 1997 Jan; 385(6612):165-8. PubMed ID: 8990120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-obese and obese agouti mice are sensitive to the anorectic effects of peptide YY(3-36) but resistant to ghrelin.
    Martin NM; Small CJ; Sajedi A; Patterson M; Ghatei MA; Bloom SR
    Int J Obes Relat Metab Disord; 2004 Jul; 28(7):886-93. PubMed ID: 15148507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperphagia, not hypometabolism, causes early onset obesity in melanocortin-4 receptor knockout mice.
    Weide K; Christ N; Moar KM; Arens J; Hinney A; Mercer JG; Eiden S; Schmidt I
    Physiol Genomics; 2003 Mar; 13(1):47-56. PubMed ID: 12644632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binge eating as a major phenotype of melanocortin 4 receptor gene mutations.
    Branson R; Potoczna N; Kral JG; Lentes KU; Hoehe MR; Horber FF
    N Engl J Med; 2003 Mar; 348(12):1096-103. PubMed ID: 12646666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that orexigenic effects of melanocortin 4 receptor antagonist HS014 are mediated by neuropeptide Y.
    Kask A; Rägo L; Korrovits P; Wikberg JE; Schiöth HB
    Biochem Biophys Res Commun; 1998 Jul; 248(2):245-9. PubMed ID: 9675121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mode of leptin action in chicken hypothalamus.
    Dridi S; Swennen Q; Decuypere E; Buyse J
    Brain Res; 2005 Jun; 1047(2):214-23. PubMed ID: 15907812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripherally administered [Nle4,D-Phe7]-alpha-melanocyte stimulating hormone increases resting metabolic rate, while peripheral agouti-related protein has no effect, in wild type C57BL/6 and ob/ob mice.
    Hoggard N; Rayner DV; Johnston SL; Speakman JR
    J Mol Endocrinol; 2004 Dec; 33(3):693-703. PubMed ID: 15591028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothalamic orexin, OX1, alphaMSH, NPY and MCRs expression in dopaminergic D2R knockout mice.
    García-Tornadú I; Díaz-Torga G; Risso GS; Silveyra P; Cataldi N; Ramirez MC; Low MJ; Libertun C; Becu-Villalobos D
    Neuropeptides; 2009 Aug; 43(4):267-74. PubMed ID: 19570576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aged-obese rats exhibit robust responses to a melanocortin agonist and antagonist despite leptin resistance.
    Zhang Y; Matheny M; Tümer N; Scarpace PJ
    Neurobiol Aging; 2004; 25(10):1349-60. PubMed ID: 15465633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular determination of agouti-related protein binding to human melanocortin-4 receptor.
    Yang Y; Chen M; Lai Y; Gantz I; Yagmurlu A; Georgeson KE; Harmon CM
    Mol Pharmacol; 2003 Jul; 64(1):94-103. PubMed ID: 12815165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of neuropeptide Y-deficient mice to feeding effectors.
    Hollopeter G; Erickson JC; Seeley RJ; Marsh DJ; Palmiter RD
    Regul Pept; 1998 Sep; 75-76():383-9. PubMed ID: 9802433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of in vivo and in vitro administration of ghrelin, leptin and neuropeptide mediators on pulsatile gonadotrophin-releasing hormone secretion from male rat hypothalamus before and after puberty.
    Lebrethon MC; Aganina A; Fournier M; Gérard A; Parent AS; Bourguignon JP
    J Neuroendocrinol; 2007 Mar; 19(3):181-8. PubMed ID: 17280591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadotropin-releasing hormone II (GnRH II) mediates the anorexigenic actions of α-melanocyte-stimulating hormone (α-MSH) and corticotropin-releasing hormone (CRH) in goldfish.
    Kang KS; Shimizu K; Azuma M; Ui Y; Nakamura K; Uchiyama M; Matsuda K
    Peptides; 2011 Jan; 32(1):31-5. PubMed ID: 20955748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diet-induced obesity causes severe but reversible leptin resistance in arcuate melanocortin neurons.
    Enriori PJ; Evans AE; Sinnayah P; Jobst EE; Tonelli-Lemos L; Billes SK; Glavas MM; Grayson BE; Perello M; Nillni EA; Grove KL; Cowley MA
    Cell Metab; 2007 Mar; 5(3):181-94. PubMed ID: 17339026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of hypothalamic NPY, AgRP, MC4R, AND IL-6 mRNA levels in young Lewis rats with early-life diet-induced obesity.
    Stofkova A; Skurlova M; Kiss A; Zelezna B; Zorad S; Jurcovicova J
    Endocr Regul; 2009 Jul; 43(3):99-106. PubMed ID: 19817504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma concentrations of alpha-MSH, AgRP and leptin in lean and obese men and their relationship to differing states of energy balance perturbation.
    Hoggard N; Johnstone AM; Faber P; Gibney ER; Elia M; Lobley G; Rayner V; Horgan G; Hunter L; Bashir S; Stubbs RJ
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):31-9. PubMed ID: 15212642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of 40 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists and the agouti-related protein (AGRP) antagonist.
    Xiang Z; Litherland SA; Sorensen NB; Proneth B; Wood MS; Shaw AM; Millard WJ; Haskell-Luevano C
    Biochemistry; 2006 Jun; 45(23):7277-88. PubMed ID: 16752916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.